StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron (REGN) Tops Q2 EPS by 61c, Revenues Beat
August 6, 2019 6:43 AM
Regeneron (NASDAQ: REGN) reported Q2 EPS of $6.02, $0.61 better than the analyst estimate of $5.41. Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Earnings
Management Comments
Next Articles
Regeneron Reports Second Quarter 2019 Financial and Operating Results
August 6, 2019 6:30 AM
Regeneron (REGN) Reports Dupixent Granted European Commission Approval for Adolescents with Moderate-to-Severe Atopic Sermatitis
August 6, 2019 5:57 AM
Regeneron (REGN) Highlights Positive Topline Results in Phase 3 Trial
August 6, 2019 5:48 AM